Stephane Asselin
About Stephane Asselin
Stephane Asselin is the National Sales Director Oncology at Bristol Myers Squibb in Montreal, Quebec, Canada, with over a decade of experience in the pharmaceutical industry.
Company
Stephane Asselin is currently employed at Bristol Myers Squibb, a prominent global biopharmaceutical company. He works out of their Montreal, Quebec, Canada office. Bristol Myers Squibb focuses on developing innovative therapies for serious diseases, with a strong emphasis on oncology, cardiology, immunology, and fibrosis.
Title
Stephane Asselin holds the position of National Sales Director Oncology at Bristol Myers Squibb. He has been in this role since April 2020. In this capacity, he oversees national sales strategies and operations for oncology products, ensuring effective market penetration and growth.
Education and Expertise
Stephane Asselin has a strong educational background in business and management. He studied International Management at the Netherlands School of Business in 1999. Prior to that, he completed a three-year program at Université du Québec à Montréal from 1996 to 1999. His education has equipped him with essential skills for his successful career in pharmaceutical sales and management.
Background
Stephane Asselin has accumulated extensive experience in the pharmaceutical industry over more than a decade. He began his career at AstraZeneca, where he served in multiple roles, including Field Sales Trainer and Area Business Manager. He later joined Pfizer as a Brand Manager and subsequently moved to Bristol Myers Squibb, where his roles have included Senior Product Manager Lung Cancer and his current position as National Sales Director Oncology.
Achievements
Throughout his career, Stephane Asselin has taken on various significant roles within the pharmaceutical industry. At AstraZeneca, he was responsible for training sales teams as a Field Sales Trainer and managing regional sales as an Area Business Manager. At Pfizer, he honed his skills in brand management. During his tenure as Senior Product Manager Lung Cancer at Bristol Myers Squibb, he developed strategies for lung cancer products before moving on to his current role, where he oversees national sales for oncology.